Affimed Announces Acceptance Of An Abstract Comparing NK Cells Redirected By Innate Cell Engagers And CAR-NK Cells For Poster Presentation At The 38th Annual Meeting Of The Society For Immunotherapy Of Cancer
Portfolio Pulse from Benzinga Newsdesk
Affimed has announced that an abstract comparing NK cells redirected by innate cell engagers and CAR-NK cells has been accepted for a poster presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer.
September 27, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Affimed's abstract acceptance for a presentation at a major immunotherapy conference could potentially increase visibility and interest in the company's research, possibly impacting its stock positively in the short term.
The acceptance of Affimed's abstract for presentation at a major conference indicates recognition of the company's work in the field of immunotherapy. This could potentially increase visibility and interest in the company's research, which could positively impact its stock in the short term. However, the actual impact will depend on the market's perception of the presented research and its potential implications for the company's future.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100